RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2182/S.1734 - The Generating Antibiotic Incentives Now Act. Supporting work to increase innovation in the development of new antibiotics. S. 1584 - The Drug Safety and Accountability Act. Supporting upstream supply chain safety issues. S. 3026 - Safeguarding America's Pharmaceuticals Act Supporting downstream supply chain issues. Implementation and rulemaking related to the Physician Payment Sunshine Act - A Medicare-related provision in the Health Reform Law focused on increasing systemic transparency. S. 3295- The Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act of 2013. Supporting report language clarifying congressional intent for the funding of the Physician Payment Sunshine Act. Improvement of safety and efficacy of medical devices. Work related to treatment of medical devices in the upcoming FDA user fee arena. S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies. H.R. 6584 The Valid Compounding Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 6638 - S.A.F.E Compounded Drugs Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 8 - The American Taxpayer Relief Act of 2012- Focused on provisions that could have an impact on the nation's public health system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Medicare/Medicaid MMM
Implementation and rulemaking related to the Physician Payment Sunshine Act- a Medicare-related provision in the health reform law focused on systemic transparency. S. 3295- The Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act of 2013. Supporting report language clarifying congressional intent for the funding of the Physician Payment Sunshine Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Pharmacy PHA
H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Potential language related to Track and Trace provisions regarding downstream supply chain safety being considered by the Senate HELP and House Energy and Commerce Committees. H.R. 6584 The Valid Compounding Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 6638 - S.A.F.E Compounded Drugs Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 8 - The American Taxpayer Relief Act of 2012- Focused on provisions that could have an impact on the nation's public health system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.